— Know what they know.
Not Investment Advice

AGEN NASDAQ

Agenus Inc.
1W: +3.6% 1M: -29.5% 3M: +0.3% YTD: +105.9% 1Y: +60.6% 3Y: -62.8% 5Y: -93.4%
$6.65
+0.49 (+7.95%)
 
Weekly Expected Move ±14.6%
$4 $5 $6 $7 $8
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 38 · $300.3M mcap · 40M float · 8.20% daily turnover · Short 66% of daily vol
Credit Risk of going bust: higher than 86% of companies Debt: 11.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the second-riskiest tenth, about 1 in 87 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.26 (down 96%), Agenus Inc. would be worth roughly what it owes.
Total debt $40.7M against a stock market value of $300.3M.
Distance to default 2.02 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $30.1M (short-term plus half of long-term), stock volatility 106.2%; Altman Z'' -40.96. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$227M +0.2% ▲
5Y CAGR: +1.1%
Total Liabilities
$505M -5.3% ▼
5Y CAGR: +3.4%
Shareholders Equity
-$271M +16.9% ▲
Cash & Investments
$3M -92.6% ▼
5Y CAGR: -50.4%
Total Debt
$335M +253.0% ▲
5Y CAGR: +43.1%
Net Debt
$332M +509.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$292M$179M$76M$40M$3M
Short-Term Investments$15M$15M$0$0$0
Cash & ST Investments$307M$193M$76M$40M$3M
Net Receivables$2M$3M$26M$407K$2M
Inventory$20M$14M$0$0$0
Other Current Assets-$17M-$11M$2M$2M$129M
Total Current Assets$332M$213M$112M$46M$133M
Property, Plant & Equip.$91M$164M$163M$147M$24M
Goodwill & Intangibles$33M$32M$29M$27M$27M
Long-Term Investments$0$0$3M$0$43M
Other Non-Current Assets$12M$7M$6M$6M-$742K
Total Non-Current Assets$134M$200M$201M$181M$93M
Total Assets$466M$414M$314M$226M$227M
— Liabilities —
Accounts Payable$30M$41M$61M$61M$83M
Short-Term Debt$728K$575K$146K$3M$155M
Deferred Revenue$12M$12M$18K$31K$1M
Other Current Liabilities$76M$101M$141M$122M$83M
Total Current Liabilities$157M$189M$256M$221M$323M
Long-Term Debt$13M$13M$13M$30M$170M
Other Non-Current Liab.$195M$202M$125M$225M$242K
Total Non-Current Liabilities$261M$280M$206M$311M$181M
Total Liabilities$418M$468M$462M$533M$505M
— Equity —
Common Stock$3M$3M$4M$236K$353K
Retained Earnings-$1.5B-$1.7B-$2.0B-$2.2B-$2.2B
Accumulated OCI$1M$915K-$955K-$1M-$439K
Total Stockholders Equity$34M-$61M-$160M-$326M-$271M
Total Liabilities & Equity$466M$414M$314M$226M$227M
— Key Metrics —
Total Debt$58M$78M$93M$95M$335M
Net Debt-$234M-$100M$17M$54M$332M
Total Investments$15M$15M$3M$0$43M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms